Navigation Links
Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events
Date:5/6/2008

Pharmacogenetic Findings May Lead to Individualized Treatment for

Schizophrenia

WASHINGTON, MAY 6 /PRNewswire-FirstCall/ -- Data presented today on Vanda Pharmaceuticals Inc.'s (Nasdaq: VNDA) investigational drug candidate, iloperidone, included its 4-week, short-term Phase III trial, as well as a pooled analysis of three long-term, 52-week trials, studying the efficacy and safety of iloperidone. Iloperidone is a 5HT2/D2 antagonist ("atypical") antipsychotic currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia. Additional data were presented identifying genetic markers that may help predict response to iloperidone, which Vanda believes could lead to unique, individualized treatment for schizophrenia. These data were presented today at the 161st American Psychiatric Association (APA) Annual Meeting in Washington, D.C.

"The data from the clinical trials studying the efficacy and safety of iloperidone suggest that iloperidone could be a useful long-term treatment option for people with schizophrenia," said Peter Weiden, M.D., Director of the Psychosis Program of the Department of Psychiatry at the University of Illinois at Chicago and one of the leading experts on adverse events of antipsychotic medications.

The data presented are part of the New Drug Application (NDA) submitted and currently under review by the FDA and demonstrate that iloperidone is effective in the short-term treatment of schizophrenia and that iloperidone is non-inferior to haloperidol in long-term maintenance measured as time to relapse over 52 weeks. In these trials, iloperidone showed short- and long- term safety with respect to movement disorders and metabolic e
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Treprostinil Data to be Presented at Annual Meeting of the American Thoracic Society
2. New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting
3. Phase 3 Data Regarding Anti-RSV Antibody To Be Presented at Pediatric Academic Societies (PAS) Annual Meeting
4. Interim Results from Boceprevir Phase II Study in Genotype 1 Treatment-Naive Hepatitis C Patients Presented At EASL
5. Final Results of Ideal Study Presented at Annual Meeting of the European Association for the Study of the Liver (EASL)
6. Data Presented at AAN Support Potential for Adjunctive use of Intravenous Lacosamide as Short-Term Replacement for Oral Treatment in Partial Epilepsy
7. Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
8. Data Presented at AAN Show That Lacosamide Significantly Reduced Pain and was Generally Well Tolerated in Patients With Diabetic Neuropathic Pain
9. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
10. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
11. Preclinical Study Presented at AACR Annual Meeting Shows Broad Anti-Cancer Potential of Peregrines anti-PS Vascular Targeting Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... N.J. , May 23, 2013 Nephros, ... commercial stage medical device company that develops and sells ... completion of its rights offering.  In addition, the concurrent ... 2011 warrants expired on May 17, 2013. ... $3.0 million from the rights offering.   A portion of ...
(Date:5/23/2013)... , May 23, 2013  A recently published clinical ... Houston, Texas , demonstrates that 3D mammography ... cancer detection. The study, "Implementation of ... Study," was led by Stephen L. Rose ... of the American Journal of Roentgenology (AJR). ...
(Date:5/23/2013)... IRVINE, Calif. , May 23, 2013 ... breast cancer may not benefit from chemotherapy and still ... announced the launch of one of the largest sources ... The new website and interactive Facebook page provide recently ... if they can safely avoid chemotherapy. "We ...
Breaking Medicine Technology:Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3
... Calif., May 16, 2011 diaDexus, Inc. (OTC Bulletin Board: ... development and commercialization of patent-protected in vitro diagnostic ... results for the first quarter of 2011. Total ... million, representing 25% growth over total revenues of $2.7 million ...
... On April 28, 2011 the New England Journal ... ongoing "Comparisons of Age-Related Macular Degeneration Treatments Trials" (CATT). ... primary market research and influence network mapping, has conducted ... to gauge their reactions on the heels of this ...
Cached Medicine Technology:diaDexus, Inc. Reports 2011 First Quarter Financial Results 2diaDexus, Inc. Reports 2011 First Quarter Financial Results 3diaDexus, Inc. Reports 2011 First Quarter Financial Results 4diaDexus, Inc. Reports 2011 First Quarter Financial Results 5AlphaDetail AlphaPulse™: Anticipated Impact of CATT Trial in Wet AMD Treatment 2
(Date:5/25/2013)... May 25, 2013 Dr. Leslie Gerstman ... procedure FDA-approved to lift skin on the neck, on the ... her practice, Medical Aesthetics. , Ultherapy is a non-surgical procedure ... natural healing process to lift the skin over time. The ... time, to see and then treat the deepest support layers ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Communities of ... Texas. It is the fifth largest media market in the ... the number one visitor destination in Texas and a major ... to the American West as it is home to many ... will enjoy from sports to the arts. Residents and locals ...
(Date:5/25/2013)... -- Many viruses and parasites that affect both dogs ... bacteria-borne illness than can result in liver or kidney ... to a veterinarian. These germs could be ... said Dr. Susan Nelson, a clinical associate professor at ... serious diseases can be fatal, even with treatment," she ...
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... Absolute Surgical Specialists, serving Sun City Center for ... throughout the country participating in Shop Local for a Cause. ... event as he understands what military families go through after ... said, “I wanted to give something back, as I not ... here too.” , Shop Local for a Cause has chosen ...
Breaking Medicine News(10 mins):Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Communities of Distinction TV Presents May Air Dates for Dallas-Ft. Worth, Texas 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Dr. Craig Amshel of Absolute Surgical Specialists Offering Bowel Prep During the Shop Local for a Cause Event 2
... ... series of free 90-minute online classes this month to help returning combat veterans and ... critical for combat veterans and families. , ... (PRWEB) November 12, 2009 -- The nonprofit PAIRS Foundation will ...
... Catholic ... , ... (PRWEB) November 11, 2009 -- Drexel University Online honored Catholic Health East ... to training and development through various forms of eLearning to meet business goals and ...
... ... and design services, Ms. McKenna and the Beyond the Box team can assist seniors and ... , ... -- The Washington, DC based relocation and design firm, Beyond the Box , is ...
... ... core lab market with largest number of highly automated QT(sm) studies. , ... Rochester, NY (PRWEB) November 11, ... and QT analysis, announced today that a top five pharmaceutical company has awarded iCardiac ...
... High levels of workplace exposure to Bisphenol-A may increase the ... Kaiser Permanente study appearing online in the journal Human ... The five-year study examined 634 workers in factories in China, ... of workers in factories where no BPA was present. The ...
... Public Health researchers will present Nov. 11 on a ... annual meeting in Philadelphia, including a study that found ... wellness program. Additional public health research findings ... faith affect how Southern African-American women use contraception? , ...
Cached Medicine News:Health News:PAIRS Foundation Offering Free Classes to Help Combat Veterans Impacted by PTSD 2Health News:PAIRS Foundation Offering Free Classes to Help Combat Veterans Impacted by PTSD 3Health News:Catholic Health East Named 2009 National Distance Learning Week Award Recipient 2Health News:Catholic Health East Named 2009 National Distance Learning Week Award Recipient 3Health News:Relocation Specialists Beyond the Box Team With Nurse to Help Facilitate Senior Moves 2Health News:Relocation Specialists Beyond the Box Team With Nurse to Help Facilitate Senior Moves 3Health News:Top Five International Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac 2Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 2Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 3Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 4Health News:Workplace BPA Exposure Increases Risk of Male Sexual Dysfunction, Kaiser Permanente Study Finds 5Health News:Worksite wellness programs may reduce employee absenteeism 2
The Perkins has been established for well over 20 years as a "world standard" for hand held applanation tonometers....
... Topcon, leader in ... offers the most advanced ... operational conveniences and totally ... Auto Refractometry and Auto ...
... examination time and ease of use makes working ... The advanced touch-screen display allows you to perform ... movement. Capture one eye on the display ... With the new features, the RC-5000 will ...
... The Worlds First Combination Unit, the M3,Marco ... Keratometer, and Non-Contact Tonometer. By combining automatic ... you to save time while providing the ... from Marco. The M3 not only saves ...
Medicine Products: